Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

被引:82
作者
Hundley, JE
Koester, SK
Troyer, DA
Hilsenbeck, SG
Subler, MA
Windle, JJ
机构
[1] CANC THERAPY & RES CTR S TEXAS,INST DRUG DEV,SAN ANTONIO,TX 78229
[2] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV ONCOL,SAN ANTONIO,TX 78284
[4] UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284
关键词
D O I
10.1128/MCB.17.2.723
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used an in vivo tumor model to evaluate the consequences of p53 tumor suppressor protein deficiency in a tissue-specific context. By breeding MMTV-ras transgenic mice, which are highly susceptible to the development of mammary and salivary tumors, with p53(-/-) mice, we generated three classes of animals which contained the MMTV-ras transgene but differed in their p53 functional status (ras/p(53+/+),ras/p53(+/-), or ras/p53(-/-)). ras/p53(-/-) mice developed tumors more rapidly than animals of the other two genotypes; however, the distribution of tumors was unexpectedly altered. Whereas the most frequently observed tumors in ras/p53(+/+) and raslp53+l- mice were of mammary origin, rasip53-/- mice developed primarily salivary tumors. In addition, the mammary and salivary tumors from ras/p53(-/-) mice consistently exhibited a number of unfavorable characteristics, including higher histologic grades, increased growth rates, and extensive genomic instability and heterogeneity, relative to tumors from ras/p53(+/+) mice. Interestingly, the increased growth rates of ras/p53(-/-) tumors appear to be due to impaired cell cycle regulation rather than decreased apoptosis, suggesting that p53-mediated tumor suppression can occur independent of its role in apoptosis.
引用
收藏
页码:723 / 731
页数:9
相关论文
共 54 条
  • [1] [Anonymous], 1994, MANIPULATING MOUSE E
  • [2] ARENDS MJ, 1994, AM J PATHOL, V144, P1045
  • [3] SUSCEPTIBILITY TO APOPTOSIS IS DIFFERENTIALLY REGULATED BY C-MYC AND MUTATED HA-RAS ONCOGENES AND IS ASSOCIATED WITH ENDONUCLEASE AVAILABILITY
    ARENDS, MJ
    MCGREGOR, AH
    TOFT, NJ
    BROWN, EJH
    WYLLIE, AH
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1127 - 1133
  • [4] AUER GU, 1994, VIRCHOWS ARCH, V424, P343
  • [5] BILLADEAU D, 1995, CANCER RES, V55, P3640
  • [6] GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS
    CANMAN, CE
    GILMER, TM
    COUTTS, SB
    KASTAN, MB
    [J]. GENES & DEVELOPMENT, 1995, 9 (05) : 600 - 611
  • [7] CLARKE AR, 1995, ONCOGENE, V11, P1913
  • [8] Cox D. R., 1984, ANAL SURVIVAL DATA
  • [9] WILD-TYPE P53 MEDIATES APOPTOSIS BY E1A, WHICH IS INHIBITED BY E1B
    DEBBAS, M
    WHITE, E
    [J]. GENES & DEVELOPMENT, 1993, 7 (04) : 546 - 554
  • [10] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221